Impact of Sodium-Glucose Cotransporter-2 Inhibitors in the Management of Chronic Kidney Disease: A Middle East and Africa Perspective

被引:1
作者
Elkeraie, Ahmed Fathi [1 ]
Al-Ghamdi, Saeed [2 ]
Abu-Alfa, Ali K. [3 ]
Alotaibi, Torki [4 ]
Alsaedi, Ali Jasim [5 ]
Alsuwaida, Abdulkareem [6 ]
Arici, Mustafa [7 ]
Ecder, Tevfik [1 ,8 ]
Ghnaimat, Mohammad [9 ]
Hafez, Mohamed Hany [10 ]
Hassan, Mohamed H. [11 ]
Sqalli, Tarik [12 ]
机构
[1] Alexandria Univ, Dept Internal Med & Nephrol, Alexandria, Egypt
[2] King Abdulaziz Univ, Coll Med, Dept Med, Jeddah, Saudi Arabia
[3] Amer Univ Beirut, Dept Internal Med, Div Nephrol & Hypertens, Beirut, Lebanon
[4] Sabah Hlth Reg, Hamed Al Essa Organ Transplant Ctr, Transplant Nephrol, Kuwait, Kuwait
[5] Univ Baghdad, Coll Med, Nephrol & Transplantat Ctr, Dept Nephrol, Baghdad, Iraq
[6] King Saud Univ, Dept Med, Riyadh, Saudi Arabia
[7] Hacettepe Univ, Fac Med, Dept Nephrol, Ankara, Turkiye
[8] Istinye Univ, Dept Med, Div Nephrol, Sch Med, Istanbul, Turkiye
[9] Specialty Hosp, Dept Nephrol, Jaber Ibn Hayyan St Shmeisani, Amman, Jordan
[10] Cairo Univ, Dept Nephrol & Med, Cairo, Egypt
[11] Dept Med, Sheikh Khalifa Med City, Abu Dhabi, U Arab Emirates
[12] Moroccan Soc Nephrol, Dept Nephrol, Casablanca, Morocco
来源
INTERNATIONAL JOURNAL OF NEPHROLOGY AND RENOVASCULAR DISEASE | 2024年 / 17卷
关键词
chronic kidney disease; nephrology referral; screening; sodium-glucose cotransporter-2 inhibitors; CARDIOVASCULAR OUTCOMES; SGLT2; INHIBITORS; PROGRESSION; ALBUMINURIA; HEALTH; RISK; DAPAGLIFLOZIN; HYPERTENSION; ELECTROLYTE; PREVALENCE;
D O I
10.2147/IJNRD.S430532
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Chronic kidney disease (CKD) is a major public health concern in the Middle East and Africa (MEA) region and a leading cause of death in patients with type 2 diabetes mellitus (T2DM) and hypertension. Early initiation of sodium-glucose cotransporter -2 inhibitors (SGLT-2i) and proper sequencing with renin-angiotensin-aldosterone system inhibitors (RAASi) in these patients may result in better clinical outcomes due to their cardioprotective properties and complementary mechanisms of action. In this review, we present guideline-based consensus recommendations by experts from the MEA region, as practical algorithms for screening, early detection, nephrology referral, and treatment pathways for CKD management in patients with hypertension and diabetes mellitus. This study will help physicians take timely and appropriate actions to provide better care to patients with CKD or those at high risk of CKD.
引用
收藏
页码:1 / 16
页数:16
相关论文
共 77 条
[1]   Chronic Kidney Disease Management in the Middle East and Africa: Concerns, Challenges, and Novel Approaches [J].
Al-Ghamdi, Saeed ;
Abu-Alfa, Ali ;
Alotaibi, Turki ;
AlSaaidi, Ali ;
AlSuwaida, Abdulkareem ;
Arici, Mustafa ;
Ecder, Tevfik ;
El Koraie, Ahmed F. ;
Ghnaimat, Mohamed ;
Hafez, Mohamed H. ;
Hassan, Mohamed ;
Sqalli, Tarik .
INTERNATIONAL JOURNAL OF NEPHROLOGY AND RENOVASCULAR DISEASE, 2023, 16 :103-112
[2]   Diabetes Prevalence, Treatment, Control, and Outcomes Among Hemodialysis Patients in the Gulf Cooperation Council Countries [J].
Al-Ghamdi, Saeed M. G. ;
Bieber, Brian ;
AlRukhaimi, Mona ;
AlSahow, Ali ;
Al Salmi, Issa ;
Al Ali, Fadwa ;
Al Aradi, Ali ;
Pecoits-Filho, Roberto ;
Robinson, Bruce M. ;
Pisoni, Ronald L. .
KIDNEY INTERNATIONAL REPORTS, 2022, 7 (07) :1093-1102
[3]   Current Management Strategies of Chronic Kidney Disease in Resource-Limited Countries [J].
Ameh, Oluwatoyin Idaomeh ;
Ekrikpo, Udeme ;
Bello, Aminu ;
Okpechi, Ikechi .
INTERNATIONAL JOURNAL OF NEPHROLOGY AND RENOVASCULAR DISEASE, 2020, 13 :239-251
[4]   Empagliflozin in Heart Failure with a Preserved Ejection Fraction [J].
Anker, Stefan D. ;
Butler, Javed ;
Filippatos, Gerasimos ;
Ferreira, Joao P. ;
Bocchi, Edimar ;
Boehm, Michael ;
Brunner-La Rocca, Hans-Peter ;
Choi, Dong-Ju ;
Chopra, Vijay ;
Chuquiure-Valenzuela, Eduardo ;
Giannetti, Nadia ;
Gomez-Mesa, Juan Esteban ;
Janssens, Stefan ;
Januzzi, James L. ;
Gonzalez-Juanatey, Jose R. ;
Merkely, Bela ;
Nicholls, Stephen J. ;
Perrone, Sergio V. ;
Pina, Ileana L. ;
Ponikowski, Piotr ;
Senni, Michele ;
Sim, David ;
Spinar, Jindrich ;
Squire, Iain ;
Taddei, Stefano ;
Tsutsui, Hiroyuki ;
Verma, Subodh ;
Vinereanu, Dragos ;
Zhang, Jian ;
Carson, Peter ;
Lam, Carolyn Su Ping ;
Marx, Nikolaus ;
Zeller, Cordula ;
Sattar, Naveed ;
Jamal, Waheed ;
Schnaidt, Sven ;
Schnee, Janet M. ;
Brueckmann, Martina ;
Pocock, Stuart J. ;
Zannad, Faiez ;
Packer, Milton .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (16) :1451-1461
[6]  
[Anonymous], 2012, KIDNEY INT SUPPL, V2, P1, DOI DOI 10.1038/KISUP.2012.1
[7]  
AstraZeneca Pharma India, Indian Society of Nephrology (ISN) and AstraZeneca India join hands this World Kidney Day to fulfil the theme of "Kidney Health for All
[8]   Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes [J].
Bakris, George L. ;
Agarwal, Rajiv ;
Anker, Stefan D. ;
Pitt, Bertram ;
Ruilope, Luis M. ;
Rossing, Peter ;
Kolkhof, Peter ;
Nowack, Christina ;
Schloemer, Patrick ;
Joseph, Amer ;
Filippatos, Gerasimos .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (23) :2219-2229
[9]   Cardiovascular, Renal, and Metabolic Outcomes of Dapagliflozin Versus Placebo in a Primary Cardiovascular Prevention Cohort: Analyses From DECLARE-TIMI 58 [J].
Cahn, Avivit ;
Raz, Itamar ;
Leiter, Lawrence A. ;
Mosenzon, Ofri ;
Murphy, Sabina A. ;
Goodrich, Erica L. ;
Yanuv, Ilan ;
Rozenberg, Aliza ;
Bhatt, Deepak L. ;
McGuire, Darren K. ;
Wilding, John P. H. ;
Gause-Nilsson, Ingrid A. M. ;
Langkilde, Anna Maria ;
Sabatine, Marc S. ;
Wiviott, Stephen D. .
DIABETES CARE, 2021, 44 (05) :1159-1167
[10]   Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes [J].
Cannon, Christopher P. ;
Pratley, Richard ;
Dagogo-Jack, Samuel ;
Mancuso, James ;
Huyck, Susan ;
Masiukiewicz, Urszula ;
Charbonnel, Bernard ;
Frederich, Robert ;
Gallo, Silvina ;
Cosentino, Francesco ;
Shih, Weichung J. ;
Gantz, Ira ;
Terra, Steven G. ;
Cherney, David Z. I. ;
McGuire, Darren K. .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (15) :1425-1435